Stay Ahead, Stay ONMINE

How aging clocks can help us understand why we age—and if we can reverse it

Be honest: Have you ever looked up someone from your childhood on social media with the sole intention of seeing how they’ve aged?  One of my colleagues, who shall remain nameless, certainly has. He recently shared a photo of a former classmate. “Can you believe we’re the same age?” he asked, with a hint of glee in his voice. A relative also delights in this pastime. “Wow, she looks like an old woman,” she’ll say when looking at a picture of someone she has known since childhood. The years certainly are kinder to some of us than others. But wrinkles and gray hairs aside, it can be difficult to know how well—or poorly—someone’s body is truly aging, under the hood. A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as elevated cholesterol or markers of inflammation), might be considered “biologically older” than a similar-age person who doesn’t have those changes. Some 80-year-olds will be weak and frail, while others are fit and active.  Doctors have long used functional tests that measure their patients’ strength or the distance they can walk, for example, or simply “eyeball” them to guess whether they look fit enough to survive some treatment regimen, says Tamir Chandra, who studies aging at the Mayo Clinic.  But over the past decade, scientists have been uncovering new methods of looking at the hidden ways our bodies are aging. What they’ve found is changing our understanding of aging itself.  “Aging clocks” are new scientific tools that can measure how our organs are wearing out, giving us insight into our mortality and health. They hint at our biological age. While chronological age is simply how many birthdays we’ve had, biological age is meant to reflect something deeper. It measures how our bodies are handling the passing of time and—perhaps—lets us know how much more of it we have left. And while you can’t change your chronological age, you just might be able to influence your biological age. It’s not just scientists who are using these clocks. Longevity influencers like Bryan Johnson often use them to make the case that they are aging backwards. “My telomeres say I’m 10 years old,” Johnson posted on X in April. The Kardashians have tried them too (Khloé was told on TV that her biological age was 12 years below her chronological age). Even my local health-food store offers biological age testing. Some are pushing the use of clocks even further, using them to sell unproven “anti-aging” supplements. The science is still new, and few experts in the field—some of whom affectionately refer to it as “clock world”—would argue that an aging clock can definitively reveal an individual’s biological age.  But their work is revealing that aging clocks can offer so much more than an insta-brag, a snake-oil pitch—or even just an eye-catching number. In fact, they are helping scientists unravel some of the deepest mysteries in biology: Why do we age? How do we age? When does aging begin? What does it even mean to age? Ultimately, and most importantly, they might soon tell us whether we can reverse the whole process. Clocks kick off The way your genes work can change. Molecules called methyl groups can attach to DNA, controlling the way genes make proteins. This process is called methylation, and it can potentially occur at millions of points along the genome. These epigenetic markers, as they are known, can switch genes on or off, or increase or decrease how much protein they make. They’re not part of our DNA, but they influence how it works. In 2011, Steve Horvath, then a biostatistician at the University of California, Los Angeles, took part in a study that was looking for links between sexual orientation and these epigenetic markers. Steve is straight; he says his twin brother, Markus, who also volunteered, is gay. That study didn’t find a link between DNA methyl­ation and sexual orientation. But when Horvath looked at the data, he noticed a different trend—a very strong link between age and methylation at around 88 points on the genome. He once told me he fell off his chair when he saw it.  Many of the affected genes had already been linked to age-related brain and cardiovascular diseases, but it wasn’t clear how methylation might be related to those diseases.  If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all. In 2013, Horvath collected methylation data from 8,000 tissue and cell samples to create what he called the Horvath clock—essentially a mathematical model that could estimate age on the basis of DNA methylation at 353 points on the genome. From a tissue sample, it was able to detect a person’s age within a range of 2.9 years. That clock changed everything. Its publication in 2013 marked the birth of “clock world.” To some, the possibilities were almost endless. If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all. The epigenetic clock was a success story in “a field that, frankly, doesn’t have a lot of success stories,” says João Pedro de Magalhães, who researches aging at the University of Birmingham, UK. It took a few years, but as more aging researchers heard about the clock, they began incorporating it into their research and even developing their own clocks. Horvath became a bit of a celebrity. Scientists started asking for selfies with him at conferences, he says. Some researchers even made T-shirts bearing the front page of his 2013 paper. Some of the many other aging clocks developed since have become notable in their own right. Examples include the PhenoAge clock, which incorporates health data such as blood cell counts and signs of inflammation along with methyl­ation, and the Dunedin Pace of Aging clock, which tells you how quickly or slowly a person is aging rather than pointing to a specific age. Many of the clocks measure methylation, but some look at other variables, such as proteins in blood or certain carbohydrate molecules that attach to such proteins. Today, there are hundreds or even thousands of clocks out there, says Chiara Herzog, who researches aging at King’s College London and is a member of the Biomarkers of Aging Consortium. Everyone has a favorite. Horvath himself favors his GrimAge clock, which was named after the Grim Reaper because it is designed to predict time to death. That clock was trained on data collected from people who were monitored for decades, many of whom died in that period. Horvath won’t use it to tell people when they might die of old age, he stresses, saying that it wouldn’t be ethical. Instead, it can be used to deliver a biological age that hints at how long a person might expect to live. Someone who is 50 but has a GrimAge of 60 can assume that, compared with the average 50-year-old, they might be a bit closer to the end. GrimAge is not perfect. While it can strongly predict time to death given the health trajectory someone is on, no aging clock can predict if someone will start smoking or get a divorce (which generally speeds aging) or suddenly take up running (which can generally slow it). “People are complicated,” Horvath tells MIT Technology Review. “There’s a huge error bar.” On the whole, the clocks are pretty good at making predictions about health and lifespan. They’ve been able to predict that people over the age of 105 have lower biological ages, which tracks given how rare it is for people to make it past that age. A higher epigenetic age has been linked to declining cognitive function and signs of Alzheimer’s disease, while better physical and cognitive fitness has been linked to a lower epigenetic age. Black-box clocks But accuracy is a challenge for all aging clocks. Part of the problem lies in how they were designed. Most of the clocks were trained to link age with methylation. The best clocks will deliver an estimate that reflects how far a person’s biology deviates from the average. Aging clocks are still judged on how well they can predict a person’s chronological age, but you don’t want them to be too close, says Lucas Paulo de Lima Camillo, head of machine learning at Shift Bioscience, who was awarded $10,000 by the Biomarkers of Aging Consortium for developing a clock that could estimate age within a range of 2.55 years. None of the clocks are precise enough to predict the biological age of a single person. Putting the same biological sample through five different clocks will give you five wildly different results.LEON EDLER “There’s this paradox,” says Camillo. If a clock is really good at predicting chronological age, that’s all it will tell you—and it probably won’t reveal much about your biological age. No one needs an aging clock to tell them how many birthdays they’ve had. Camillo says he’s noticed that when the clocks get too close to “perfect” age prediction, they actually become less accurate at predicting mortality. Therein lies the other central issue for scientists who develop and use aging clocks: What is the thing they are really measuring? It is a difficult question for a field whose members notoriously fail to agree on the basics. (Everything from the definition of aging to how it occurs and why is up for debate among the experts.) They do agree that aging is incredibly complex. A methylation-based aging clock might tell you about how that collection of chemical markers compares across individuals, but at best, it’s only giving you an idea of their “epigenetic age,” says Chandra. There are probably plenty of other biological markers that might reveal other aspects of aging, he says: “None of the clocks measure everything.”  We don’t know why some methyl groups appear or disappear with age, either. Are these changes causing damage? Or are they a by-product of it? Are the epigenetic patterns seen in a 90-year-old a sign of deterioration? Or have they been responsible for keeping that person alive into very old age? To make matters even more complicated, two different clocks can give similar answers by measuring methylation at entirely different regions of the genome. No one knows why, or which regions might be the best ones to focus on. “The biomarkers have this black-box quality,” says Jesse Poganik at Brigham and Women’s Hospital in Boston. “Some of them are probably causal, some of them may be adaptive … and some of them may just be neutral”: either “there’s no reason for them not to happen” or “they just happen by random chance.” What we know is that, as things stand, none of the clocks are precise enough to predict the biological age of a single person (sorry, Khloé). Putting the same biological sample through five different clocks will give you five wildly different results. Even the same clock can give you different answers if you put a sample through it more than once. “They’re not yet individually predictive,” says Herzog. “We don’t know what [a clock result] means for a person, [or if] they’re more or less likely to develop disease.” And it’s why plenty of aging researchers—even those who regularly use the clocks in their work—haven’t bothered to measure their own epigenetic age. “Let’s say I do a clock and it says that my biological age … is five years older than it should be,” says Magalhães. “So what?” He shrugs. “I don’t see much point in it.” You might think this lack of clarity would make aging clocks pretty useless in a clinical setting. But plenty of clinics are offering them anyway. Some longevity clinics are more careful, and will regularly test their patients with a range of clocks, noting their results and tracking them over time. Others will simply offer an estimate of biological age as part of a longevity treatment package. And then there are the people who use aging clocks to sell supplements. While no drug or supplement has been definitively shown to make people live longer, that hasn’t stopped the lightly regulated wellness industry from pushing a range of “treatments” that range from lotions to herbal pills all the way through to stem-cell injections. Some of these people come to aging meetings. I was in the audience at an event when one CEO took to the stage to claim he had reversed his own biological age by 18 years—thanks to the supplement he was selling. Tom Weldon of Ponce de Leon Health told us his gray hair was turning brown. His biological age was supposedly reversing so rapidly that he had reached “longevity escape velocity.” But if the people who buy his supplements expect some kind of Benjamin Button effect, they might be disappointed. His company hasn’t yet conducted a randomized controlled trial to demonstrate any anti-aging effects of that supplement, called Rejuvant. Weldon says that such a trial would take years and cost millions of dollars, and that he’d “have to increase the price of our product more than four times” to pay for one. (The company has so far tested the active ingredient in mice and carried out a provisional trial in people.) More generally, Horvath says he “gets a bad taste in [his] mouth” when people use the clocks to sell products and “make a quick buck.” But he thinks that most of those sellers have genuine faith in both the clocks and their products. “People truly believe their own nonsense,” he says. “They are so passionate about what they discovered, they fall into this trap of believing [their] own prejudices.”  The accuracy of the clocks is at a level that makes them useful for research, but not for individual predictions. Even if a clock did tell someone they were five years younger than their chronological age, that wouldn’t necessarily mean the person could expect to live five years longer, says Magalhães. “The field of aging has long been a rich ground for snake-oil salesmen and hype,” he says. “It comes with the territory.” (Weldon, for his part, says Rejuvant is the only product that has “clinically meaningful” claims.)  In any case, Magalhães adds that he thinks any publicity is better than no publicity. And there’s the rub. Most people in the longevity field seem to have mixed feelings about the trendiness of aging clocks and how they are being used. They’ll agree that the clocks aren’t ready for consumer prime time, but they tend to appreciate the attention. Longevity research is expensive, after all. With a surge in funding and an explosion in the number of biotech companies working on longevity, aging scientists are hopeful that innovation and progress will follow.  So they want to be sure that the reputation of aging clocks doesn’t end up being tarnished by association. Because while influencers and supplement sellers are using their “biological ages” to garner attention, scientists are now using these clocks to make some remarkable discoveries. Discoveries that are changing the way we think about aging. How to be young again Two little mice lie side by side, anesthetized and unconscious, as Jim White prepares his scalpel. The animals are of the same breed but look decidedly different. One is a youthful three-month-old, its fur thick, black, and glossy. By comparison, the second mouse, a 20-month-old, looks a little the worse for wear. Its fur is graying and patchy. Its whiskers are short, and it generally looks kind of frail. But the two mice are about to have a lot more in common. White, with some help from a colleague, makes incisions along the side of each mouse’s body and into the upper part of an arm and leg on the same side. He then carefully stitches the two animals together—membranes, fascia, and skin.  The procedure takes around an hour, and the mice are then roused from their anesthesia. At first, the two still-groggy animals pull away from each other. But within a few days, they seem to have accepted that they now share their bodies. Soon their circulatory systems will fuse, and the animals will share a blood flow too. “People are complicated. There’s a huge error bar.” — Steve Horvath, former biostatistician at the University of California, Los AngelesLEON EDLER White, who studies aging at Duke University, has been stitching mice together for years; he has performed this strange procedure, known as heterochronic parabiosis, more than a hundred times. And he’s seen a curious phenomenon occur. The older mice appear to benefit from the arrangement. They seem to get younger. Experiments with heterochronic parabiosis have been performed for decades, but typically scientists keep the mice attached to each other for only a few weeks, says White. In their experiment, he and his colleagues left the mice attached for three months—equivalent to around 10 human years. The team then carefully separated the animals to assess how each of them had fared. “You’d think that they’d want to separate immediately,” says White. “But when you detach them … they kind of follow each other around.” The most striking result of that experiment was that the older mice who had been attached to a younger mouse ended up living longer than other mice of a similar age. “[They lived] around 10% longer, but [they] also maintained a lot of [their] function,” says White. They were more active and maintained their strength for longer, he adds. When his colleagues, including Poganik, applied aging clocks to the mice, they found that their epigenetic ages were lower than expected. “The young circulation slowed aging in the old mice,” says White. The effect seemed to last, too—at least for a little while. “It preserved that youthful state for longer than we expected,” he says. The young mice went the other way and appeared biologically older, both while they were attached to the old mice and shortly after they were detached. But in their case, the effect seemed to be short-lived, says White: “The young mice went back to being young again.”  To White, this suggests that something about the “youthful state” might be programmed in some way. That perhaps it is written into our DNA. Maybe we don’t have to go through the biological process of aging.  This gets at a central debate in the aging field: What is aging, and why does it happen? Some believe it’s simply a result of accumulated damage. Some believe that the aging process is programmed; just as we grow limbs, develop a brain, reach puberty, and experience menopause, we are destined to deteriorate. Others think programs that play an important role in our early development just turn out to be harmful later in life by chance. And there are some scientists who agree with all of the above. White’s theory is that being old is just “a loss of youth,” he says. If that’s the case, there’s a silver lining: Knowing how youth is lost might point toward a way to somehow regain it, perhaps by restoring those youthful programs in some way.  Dogs and dolphins Horvath’s eponymous clock was developed by measuring methylation in DNA samples taken from tissues around the body. It seems to represent aging in all these tissues, which is why Horvath calls it a pan-tissue clock. Given that our organs are thought to age differently, it was remarkable that a single clock could measure aging in so many of them. But Horvath had ambitious plans for an even more universal clock: a pan-species model that could measure aging in all mammals. He started out, in 2017, with an email campaign that involved asking hundreds of scientists around the world to share samples of tissues from animals they had worked with. He tried zoos, too.    The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it. “I learned that people had spent careers collecting [animal] tissues,” he says. “They had freezers full of [them].” Amenable scientists would ship those frozen tissues, or just DNA, to Horvath’s lab in California, where he would use them to train a new model. Horvath says he initially set out to profile 30 different species. But he ended up receiving around 15,000 samples from 200 scientists, representing 348 species—including everything from dogs to dolphins. Could a single clock really predict age in all of them? “I truly felt it would fail,” says Horvath. “But it turned out that I was completely wrong.” He and his colleagues developed a clock that assessed methylation at 36,000 locations on the genome. The result, which was published in 2023 as the pan-mammalian clock, can estimate the age of any mammal and even the maximum lifespan of the species. The data set is open to anyone who wants to download it, he adds: “I hope people will mine the data to find the secret of how to extend a healthy lifespan.” The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it. Comparisons between mammals also support the idea that the slower methylation changes occur, the longer the lifespan of the animal, says Nelly Olova, an epigeneticist who researches aging at the University of Edinburgh in the UK. “DNA methylation slowly erodes with age,” she says. “We still have the instructions in place, but they become a little messier.” The research in different mammals suggests that cells can take only so much change before they stop functioning. “There’s a finite amount of change that the cell can tolerate,” she says. “If the instructions become too messy and noisy … it cannot support life.” Olova has been investigating exactly when aging clocks first begin to tick—in other words, the point at which aging starts. Clocks can be trained on data from volunteers, and by matching the patterns of methylation on their DNA to their chronological age. The trained clocks are then typically used to estimate the biological age of adults. But they can also be used on samples from children. Or babies. They can be used to work out the biological age of cells that make up embryos.  In her research, Olova used adult skin cells, which—thanks to Nobel Prize–winning research in the 2000s—can be “reprogrammed” back to a state resembling that of the pluripotent stem cells found in embryos. When Olova and her colleagues used a “partial reprogramming” approach to take cells close to that state, they found that the closer they got to the entirely reprogrammed state, the “younger” the cells were.  It was around 20 days after the cells had been reprogrammed into stem cells that they reached the biological age of zero according to the clock used, says Olova. “It was a bit surreal,” she says. “The pluripotent cells measure as minus 0.5; they’re slightly below zero.” Vadim Gladyshev, a prominent aging researcher at Harvard University, has since proposed that the same negative level of aging might apply to embryos. After all, some kind of rejuvenation happens during the early stages of embryo formation—an aged egg cell and an aged sperm cell somehow create a brand-new cell. The slate is wiped clean. Gladyshev calls this point “ground zero.” He posits that it’s reached sometime during the “mid-embryonic state.” At this point, aging begins. And so does “organismal life,” he argues. “It’s interesting how this coincides with philosophical questions about when life starts,” says Olova.  Some have argued that life begins when sperm meets egg, while others have suggested that the point when embryonic cells start to form some kind of unified structure is what counts. The ground zero point is when the body plan is set out and cells begin to organize accordingly, she says. “Before that, it’s just a bunch of cells.” This doesn’t mean that life begins at the embryonic state, but it does suggest that this is when aging begins—perhaps as the result of “a generational clearance of damage,” says Poganik. It is early days—no pun intended—for this research, and the science is far from settled. But knowing when aging begins could help inform attempts to rewind the clock. If scientists can pinpoint an ideal biological age for cells, perhaps they can find ways to get old cells back to that state. There might be a way to slow aging once cells reach a certain biological age, too.  “Presumably, there may be opportunities for targeting aging before … you’re full of gray hair,” says Poganik. “It could mean that there is an ideal window for intervention which is much earlier than our current geriatrics-based approach.” When young meets old When White first started stitching mice together, he would sit and watch them for hours. “I was like, look at them go! They’re together, and they don’t even care!” he says. Since then, he’s learned a few tricks. He tends to work with female mice, for instance—the males tend to bicker and nip at each other, he says. The females, on the other hand, seem to get on well.  The effect their partnership appears to have on their biological ages, if only temporarily, is among the ways aging clocks are helping us understand that biological age is plastic to some degree. White and his colleagues have also found, for instance, that stress seems to increase biological age, but that the effect can be reversed once the stress stops. Both pregnancy and covid-19 infections have a similar reversible effect. Poganik wonders if this finding might have applications for human organ transplants. Perhaps there’s a way to measure the biological age of an organ before it is transplanted and somehow rejuvenate organs before surgery.  But new data from aging clocks suggests that this might be more complicated than it sounds. Poganik and his colleagues have been using methylation clocks to measure the biological age of samples taken from recently transplanted hearts in living people.  If being old is simply a case of losing our youthfulness, then that might give us a clue to how we can somehow regain it. Young hearts do well in older bodies, but the biological age of these organs eventually creeps up to match that of their recipient. The same is true for older hearts in younger bodies, says Poganik, who has not yet published his findings. “After a few months, the tissue may assimilate the biological age of the organism,” he says.  If that’s the case, the benefits of young organs might be short-lived. It also suggests that scientists working on ways to rejuvenate individual organs may need to focus their anti-aging efforts on more systemic means of rejuvenation—for example, stem cells that repopulate the blood. Reprogramming these cells to a youthful state, perhaps one a little closer to “ground zero,” might be the way to go. Whole-body rejuvenation might be some way off, but scientists are still hopeful that aging clocks might help them find a way to reverse aging in people. “We have the machinery to reset our epigenetic clock to a more youthful state,” says White. “That means we have the ability to turn the clock backwards.” 

Be honest: Have you ever looked up someone from your childhood on social media with the sole intention of seeing how they’ve aged? 

One of my colleagues, who shall remain nameless, certainly has. He recently shared a photo of a former classmate. “Can you believe we’re the same age?” he asked, with a hint of glee in his voice. A relative also delights in this pastime. “Wow, she looks like an old woman,” she’ll say when looking at a picture of someone she has known since childhood. The years certainly are kinder to some of us than others.

But wrinkles and gray hairs aside, it can be difficult to know how well—or poorly—someone’s body is truly aging, under the hood. A person who develops age-related diseases earlier in life, or has other biological changes associated with aging (such as elevated cholesterol or markers of inflammation), might be considered “biologically older” than a similar-age person who doesn’t have those changes. Some 80-year-olds will be weak and frail, while others are fit and active. 

Doctors have long used functional tests that measure their patients’ strength or the distance they can walk, for example, or simply “eyeball” them to guess whether they look fit enough to survive some treatment regimen, says Tamir Chandra, who studies aging at the Mayo Clinic. 

But over the past decade, scientists have been uncovering new methods of looking at the hidden ways our bodies are aging. What they’ve found is changing our understanding of aging itself. 

“Aging clocks” are new scientific tools that can measure how our organs are wearing out, giving us insight into our mortality and health. They hint at our biological age. While chronological age is simply how many birthdays we’ve had, biological age is meant to reflect something deeper. It measures how our bodies are handling the passing of time and—perhaps—lets us know how much more of it we have left. And while you can’t change your chronological age, you just might be able to influence your biological age.

It’s not just scientists who are using these clocks. Longevity influencers like Bryan Johnson often use them to make the case that they are aging backwards. “My telomeres say I’m 10 years old,” Johnson posted on X in April. The Kardashians have tried them too (Khloé was told on TV that her biological age was 12 years below her chronological age). Even my local health-food store offers biological age testing. Some are pushing the use of clocks even further, using them to sell unproven “anti-aging” supplements.

The science is still new, and few experts in the field—some of whom affectionately refer to it as “clock world”—would argue that an aging clock can definitively reveal an individual’s biological age. 

But their work is revealing that aging clocks can offer so much more than an insta-brag, a snake-oil pitch—or even just an eye-catching number. In fact, they are helping scientists unravel some of the deepest mysteries in biology: Why do we age? How do we age? When does aging begin? What does it even mean to age?

Ultimately, and most importantly, they might soon tell us whether we can reverse the whole process.

Clocks kick off

The way your genes work can change. Molecules called methyl groups can attach to DNA, controlling the way genes make proteins. This process is called methylation, and it can potentially occur at millions of points along the genome. These epigenetic markers, as they are known, can switch genes on or off, or increase or decrease how much protein they make. They’re not part of our DNA, but they influence how it works.

In 2011, Steve Horvath, then a biostatistician at the University of California, Los Angeles, took part in a study that was looking for links between sexual orientation and these epigenetic markers. Steve is straight; he says his twin brother, Markus, who also volunteered, is gay.

That study didn’t find a link between DNA methyl­ation and sexual orientation. But when Horvath looked at the data, he noticed a different trend—a very strong link between age and methylation at around 88 points on the genome. He once told me he fell off his chair when he saw it

Many of the affected genes had already been linked to age-related brain and cardiovascular diseases, but it wasn’t clear how methylation might be related to those diseases. 

If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all.

In 2013, Horvath collected methylation data from 8,000 tissue and cell samples to create what he called the Horvath clock—essentially a mathematical model that could estimate age on the basis of DNA methylation at 353 points on the genome. From a tissue sample, it was able to detect a person’s age within a range of 2.9 years.

That clock changed everything. Its publication in 2013 marked the birth of “clock world.” To some, the possibilities were almost endless. If a model could work out what average aging looks like, it could potentially estimate whether someone was aging unusually fast or slowly. It could transform medicine and fast-track the search for an anti-aging drug. It could help us understand what aging is, and why it happens at all.

The epigenetic clock was a success story in “a field that, frankly, doesn’t have a lot of success stories,” says João Pedro de Magalhães, who researches aging at the University of Birmingham, UK.

It took a few years, but as more aging researchers heard about the clock, they began incorporating it into their research and even developing their own clocks. Horvath became a bit of a celebrity. Scientists started asking for selfies with him at conferences, he says. Some researchers even made T-shirts bearing the front page of his 2013 paper.

Some of the many other aging clocks developed since have become notable in their own right. Examples include the PhenoAge clock, which incorporates health data such as blood cell counts and signs of inflammation along with methyl­ation, and the Dunedin Pace of Aging clock, which tells you how quickly or slowly a person is aging rather than pointing to a specific age. Many of the clocks measure methylation, but some look at other variables, such as proteins in blood or certain carbohydrate molecules that attach to such proteins.

Today, there are hundreds or even thousands of clocks out there, says Chiara Herzog, who researches aging at King’s College London and is a member of the Biomarkers of Aging Consortium. Everyone has a favorite. Horvath himself favors his GrimAge clock, which was named after the Grim Reaper because it is designed to predict time to death.

That clock was trained on data collected from people who were monitored for decades, many of whom died in that period. Horvath won’t use it to tell people when they might die of old age, he stresses, saying that it wouldn’t be ethical. Instead, it can be used to deliver a biological age that hints at how long a person might expect to live. Someone who is 50 but has a GrimAge of 60 can assume that, compared with the average 50-year-old, they might be a bit closer to the end.

GrimAge is not perfect. While it can strongly predict time to death given the health trajectory someone is on, no aging clock can predict if someone will start smoking or get a divorce (which generally speeds aging) or suddenly take up running (which can generally slow it). “People are complicated,” Horvath tells MIT Technology Review. “There’s a huge error bar.”

On the whole, the clocks are pretty good at making predictions about health and lifespan. They’ve been able to predict that people over the age of 105 have lower biological ages, which tracks given how rare it is for people to make it past that age. A higher epigenetic age has been linked to declining cognitive function and signs of Alzheimer’s disease, while better physical and cognitive fitness has been linked to a lower epigenetic age.

Black-box clocks

But accuracy is a challenge for all aging clocks. Part of the problem lies in how they were designed. Most of the clocks were trained to link age with methylation. The best clocks will deliver an estimate that reflects how far a person’s biology deviates from the average. Aging clocks are still judged on how well they can predict a person’s chronological age, but you don’t want them to be too close, says Lucas Paulo de Lima Camillo, head of machine learning at Shift Bioscience, who was awarded $10,000 by the Biomarkers of Aging Consortium for developing a clock that could estimate age within a range of 2.55 years.

a cartoon alarm clock shrugging
None of the clocks are precise enough to predict the biological age of a single person. Putting the same biological sample through five different clocks will give you five wildly different results.
LEON EDLER

“There’s this paradox,” says Camillo. If a clock is really good at predicting chronological age, that’s all it will tell you—and it probably won’t reveal much about your biological age. No one needs an aging clock to tell them how many birthdays they’ve had. Camillo says he’s noticed that when the clocks get too close to “perfect” age prediction, they actually become less accurate at predicting mortality.

Therein lies the other central issue for scientists who develop and use aging clocks: What is the thing they are really measuring? It is a difficult question for a field whose members notoriously fail to agree on the basics. (Everything from the definition of aging to how it occurs and why is up for debate among the experts.)

They do agree that aging is incredibly complex. A methylation-based aging clock might tell you about how that collection of chemical markers compares across individuals, but at best, it’s only giving you an idea of their “epigenetic age,” says Chandra. There are probably plenty of other biological markers that might reveal other aspects of aging, he says: “None of the clocks measure everything.” 

We don’t know why some methyl groups appear or disappear with age, either. Are these changes causing damage? Or are they a by-product of it? Are the epigenetic patterns seen in a 90-year-old a sign of deterioration? Or have they been responsible for keeping that person alive into very old age?

To make matters even more complicated, two different clocks can give similar answers by measuring methylation at entirely different regions of the genome. No one knows why, or which regions might be the best ones to focus on.

“The biomarkers have this black-box quality,” says Jesse Poganik at Brigham and Women’s Hospital in Boston. “Some of them are probably causal, some of them may be adaptive … and some of them may just be neutral”: either “there’s no reason for them not to happen” or “they just happen by random chance.”

What we know is that, as things stand, none of the clocks are precise enough to predict the biological age of a single person (sorry, Khloé). Putting the same biological sample through five different clocks will give you five wildly different results.

Even the same clock can give you different answers if you put a sample through it more than once. “They’re not yet individually predictive,” says Herzog. “We don’t know what [a clock result] means for a person, [or if] they’re more or less likely to develop disease.”

And it’s why plenty of aging researchers—even those who regularly use the clocks in their work—haven’t bothered to measure their own epigenetic age. “Let’s say I do a clock and it says that my biological age … is five years older than it should be,” says Magalhães. “So what?” He shrugs. “I don’t see much point in it.”

You might think this lack of clarity would make aging clocks pretty useless in a clinical setting. But plenty of clinics are offering them anyway. Some longevity clinics are more careful, and will regularly test their patients with a range of clocks, noting their results and tracking them over time. Others will simply offer an estimate of biological age as part of a longevity treatment package.

And then there are the people who use aging clocks to sell supplements. While no drug or supplement has been definitively shown to make people live longer, that hasn’t stopped the lightly regulated wellness industry from pushing a range of “treatments” that range from lotions to herbal pills all the way through to stem-cell injections.

Some of these people come to aging meetings. I was in the audience at an event when one CEO took to the stage to claim he had reversed his own biological age by 18 years—thanks to the supplement he was selling. Tom Weldon of Ponce de Leon Health told us his gray hair was turning brown. His biological age was supposedly reversing so rapidly that he had reached “longevity escape velocity.”

But if the people who buy his supplements expect some kind of Benjamin Button effect, they might be disappointed. His company hasn’t yet conducted a randomized controlled trial to demonstrate any anti-aging effects of that supplement, called Rejuvant. Weldon says that such a trial would take years and cost millions of dollars, and that he’d “have to increase the price of our product more than four times” to pay for one. (The company has so far tested the active ingredient in mice and carried out a provisional trial in people.)

More generally, Horvath says he “gets a bad taste in [his] mouth” when people use the clocks to sell products and “make a quick buck.” But he thinks that most of those sellers have genuine faith in both the clocks and their products. “People truly believe their own nonsense,” he says. “They are so passionate about what they discovered, they fall into this trap of believing [their] own prejudices.” 

The accuracy of the clocks is at a level that makes them useful for research, but not for individual predictions. Even if a clock did tell someone they were five years younger than their chronological age, that wouldn’t necessarily mean the person could expect to live five years longer, says Magalhães. “The field of aging has long been a rich ground for snake-oil salesmen and hype,” he says. “It comes with the territory.” (Weldon, for his part, says Rejuvant is the only product that has “clinically meaningful” claims.) 

In any case, Magalhães adds that he thinks any publicity is better than no publicity.

And there’s the rub. Most people in the longevity field seem to have mixed feelings about the trendiness of aging clocks and how they are being used. They’ll agree that the clocks aren’t ready for consumer prime time, but they tend to appreciate the attention. Longevity research is expensive, after all. With a surge in funding and an explosion in the number of biotech companies working on longevity, aging scientists are hopeful that innovation and progress will follow. 

So they want to be sure that the reputation of aging clocks doesn’t end up being tarnished by association. Because while influencers and supplement sellers are using their “biological ages” to garner attention, scientists are now using these clocks to make some remarkable discoveries. Discoveries that are changing the way we think about aging.

How to be young again

Two little mice lie side by side, anesthetized and unconscious, as Jim White prepares his scalpel. The animals are of the same breed but look decidedly different. One is a youthful three-month-old, its fur thick, black, and glossy. By comparison, the second mouse, a 20-month-old, looks a little the worse for wear. Its fur is graying and patchy. Its whiskers are short, and it generally looks kind of frail.

But the two mice are about to have a lot more in common. White, with some help from a colleague, makes incisions along the side of each mouse’s body and into the upper part of an arm and leg on the same side. He then carefully stitches the two animals together—membranes, fascia, and skin. 

The procedure takes around an hour, and the mice are then roused from their anesthesia. At first, the two still-groggy animals pull away from each other. But within a few days, they seem to have accepted that they now share their bodies. Soon their circulatory systems will fuse, and the animals will share a blood flow too.

cartoon man in profile with a stick of a wrist watch around a lit stick of dynamite in his mouth
“People are complicated. There’s a huge error bar.” — Steve Horvath, former biostatistician at the University of California, Los Angeles
LEON EDLER

White, who studies aging at Duke University, has been stitching mice together for years; he has performed this strange procedure, known as heterochronic parabiosis, more than a hundred times. And he’s seen a curious phenomenon occur. The older mice appear to benefit from the arrangement. They seem to get younger.

Experiments with heterochronic parabiosis have been performed for decades, but typically scientists keep the mice attached to each other for only a few weeks, says White. In their experiment, he and his colleagues left the mice attached for three months—equivalent to around 10 human years. The team then carefully separated the animals to assess how each of them had fared. “You’d think that they’d want to separate immediately,” says White. “But when you detach them … they kind of follow each other around.”

The most striking result of that experiment was that the older mice who had been attached to a younger mouse ended up living longer than other mice of a similar age. “[They lived] around 10% longer, but [they] also maintained a lot of [their] function,” says White. They were more active and maintained their strength for longer, he adds.

When his colleagues, including Poganik, applied aging clocks to the mice, they found that their epigenetic ages were lower than expected. “The young circulation slowed aging in the old mice,” says White. The effect seemed to last, too—at least for a little while. “It preserved that youthful state for longer than we expected,” he says.

The young mice went the other way and appeared biologically older, both while they were attached to the old mice and shortly after they were detached. But in their case, the effect seemed to be short-lived, says White: “The young mice went back to being young again.” 

To White, this suggests that something about the “youthful state” might be programmed in some way. That perhaps it is written into our DNA. Maybe we don’t have to go through the biological process of aging. 

This gets at a central debate in the aging field: What is aging, and why does it happen? Some believe it’s simply a result of accumulated damage. Some believe that the aging process is programmed; just as we grow limbs, develop a brain, reach puberty, and experience menopause, we are destined to deteriorate. Others think programs that play an important role in our early development just turn out to be harmful later in life by chance. And there are some scientists who agree with all of the above.

White’s theory is that being old is just “a loss of youth,” he says. If that’s the case, there’s a silver lining: Knowing how youth is lost might point toward a way to somehow regain it, perhaps by restoring those youthful programs in some way. 

Dogs and dolphins

Horvath’s eponymous clock was developed by measuring methylation in DNA samples taken from tissues around the body. It seems to represent aging in all these tissues, which is why Horvath calls it a pan-tissue clock. Given that our organs are thought to age differently, it was remarkable that a single clock could measure aging in so many of them.

But Horvath had ambitious plans for an even more universal clock: a pan-species model that could measure aging in all mammals. He started out, in 2017, with an email campaign that involved asking hundreds of scientists around the world to share samples of tissues from animals they had worked with. He tried zoos, too.   

The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it.

“I learned that people had spent careers collecting [animal] tissues,” he says. “They had freezers full of [them].” Amenable scientists would ship those frozen tissues, or just DNA, to Horvath’s lab in California, where he would use them to train a new model.

Horvath says he initially set out to profile 30 different species. But he ended up receiving around 15,000 samples from 200 scientists, representing 348 species—including everything from dogs to dolphins. Could a single clock really predict age in all of them?

“I truly felt it would fail,” says Horvath. “But it turned out that I was completely wrong.” He and his colleagues developed a clock that assessed methylation at 36,000 locations on the genome. The result, which was published in 2023 as the pan-mammalian clock, can estimate the age of any mammal and even the maximum lifespan of the species. The data set is open to anyone who wants to download it, he adds: “I hope people will mine the data to find the secret of how to extend a healthy lifespan.”

The pan-mammalian clock suggests that there is something universal about aging—not just that all mammals experience it in a similar way, but that a similar set of genetic or epigenetic factors might be responsible for it.

Comparisons between mammals also support the idea that the slower methylation changes occur, the longer the lifespan of the animal, says Nelly Olova, an epigeneticist who researches aging at the University of Edinburgh in the UK. “DNA methylation slowly erodes with age,” she says. “We still have the instructions in place, but they become a little messier.” The research in different mammals suggests that cells can take only so much change before they stop functioning.

“There’s a finite amount of change that the cell can tolerate,” she says. “If the instructions become too messy and noisy … it cannot support life.”

Olova has been investigating exactly when aging clocks first begin to tick—in other words, the point at which aging starts. Clocks can be trained on data from volunteers, and by matching the patterns of methylation on their DNA to their chronological age. The trained clocks are then typically used to estimate the biological age of adults. But they can also be used on samples from children. Or babies. They can be used to work out the biological age of cells that make up embryos. 

In her research, Olova used adult skin cells, which—thanks to Nobel Prize–winning research in the 2000s—can be “reprogrammed” back to a state resembling that of the pluripotent stem cells found in embryos. When Olova and her colleagues used a “partial reprogramming” approach to take cells close to that state, they found that the closer they got to the entirely reprogrammed state, the “younger” the cells were. 

It was around 20 days after the cells had been reprogrammed into stem cells that they reached the biological age of zero according to the clock used, says Olova. “It was a bit surreal,” she says. “The pluripotent cells measure as minus 0.5; they’re slightly below zero.”

Vadim Gladyshev, a prominent aging researcher at Harvard University, has since proposed that the same negative level of aging might apply to embryos. After all, some kind of rejuvenation happens during the early stages of embryo formation—an aged egg cell and an aged sperm cell somehow create a brand-new cell. The slate is wiped clean.

Gladyshev calls this point “ground zero.” He posits that it’s reached sometime during the “mid-embryonic state.” At this point, aging begins. And so does “organismal life,” he argues. “It’s interesting how this coincides with philosophical questions about when life starts,” says Olova. 

Some have argued that life begins when sperm meets egg, while others have suggested that the point when embryonic cells start to form some kind of unified structure is what counts. The ground zero point is when the body plan is set out and cells begin to organize accordingly, she says. “Before that, it’s just a bunch of cells.”

This doesn’t mean that life begins at the embryonic state, but it does suggest that this is when aging begins—perhaps as the result of “a generational clearance of damage,” says Poganik.

It is early days—no pun intended—for this research, and the science is far from settled. But knowing when aging begins could help inform attempts to rewind the clock. If scientists can pinpoint an ideal biological age for cells, perhaps they can find ways to get old cells back to that state. There might be a way to slow aging once cells reach a certain biological age, too. 

“Presumably, there may be opportunities for targeting aging before … you’re full of gray hair,” says Poganik. “It could mean that there is an ideal window for intervention which is much earlier than our current geriatrics-based approach.”

When young meets old

When White first started stitching mice together, he would sit and watch them for hours. “I was like, look at them go! They’re together, and they don’t even care!” he says. Since then, he’s learned a few tricks. He tends to work with female mice, for instance—the males tend to bicker and nip at each other, he says. The females, on the other hand, seem to get on well. 

The effect their partnership appears to have on their biological ages, if only temporarily, is among the ways aging clocks are helping us understand that biological age is plastic to some degree. White and his colleagues have also found, for instance, that stress seems to increase biological age, but that the effect can be reversed once the stress stops. Both pregnancy and covid-19 infections have a similar reversible effect.

Poganik wonders if this finding might have applications for human organ transplants. Perhaps there’s a way to measure the biological age of an organ before it is transplanted and somehow rejuvenate organs before surgery. 

But new data from aging clocks suggests that this might be more complicated than it sounds. Poganik and his colleagues have been using methylation clocks to measure the biological age of samples taken from recently transplanted hearts in living people. 

If being old is simply a case of losing our youthfulness, then that might give us a clue to how we can somehow regain it.

Young hearts do well in older bodies, but the biological age of these organs eventually creeps up to match that of their recipient. The same is true for older hearts in younger bodies, says Poganik, who has not yet published his findings. “After a few months, the tissue may assimilate the biological age of the organism,” he says. 

If that’s the case, the benefits of young organs might be short-lived. It also suggests that scientists working on ways to rejuvenate individual organs may need to focus their anti-aging efforts on more systemic means of rejuvenation—for example, stem cells that repopulate the blood. Reprogramming these cells to a youthful state, perhaps one a little closer to “ground zero,” might be the way to go.

Whole-body rejuvenation might be some way off, but scientists are still hopeful that aging clocks might help them find a way to reverse aging in people.

“We have the machinery to reset our epigenetic clock to a more youthful state,” says White. “That means we have the ability to turn the clock backwards.” 

Shape
Shape
Stay Ahead

Explore More Insights

Stay ahead with more perspectives on cutting-edge power, infrastructure, energy,  bitcoin and AI solutions. Explore these articles to uncover strategies and insights shaping the future of industries.

Shape

Chinese cyberspies target VMware vSphere for long-term persistence

Designed to work in virtualized environments The CISA, NSA, and Canadian Cyber Center analysts note that some of the BRICKSTORM samples are virtualization-aware and they create a virtual socket (VSOCK) interface that enables inter-VM communication and data exfiltration. The malware also checks the environment upon execution to ensure it’s running

Read More »

IBM boosts DNS protection for multicloud operations

“In addition to this DNS synchronization, you can publish DNS configurations to your Amazon Simple Storage Service (S3) bucket. As you implement DNS changes, the S3 bucket will automatically update. The ability to store multiple configurations in your S3 bucket allows you to choose the most appropriate restore point if

Read More »

Cloudflare firewall reacts badly to React exploit mitigation

During the same window, Downdetector saw a spike in problem reports for enterprise services including Shopify, Zoom, Claude AI, and Amazon Web Services, and a host of consumer services from games to dating apps. Cloudflare explained the outage on its service status page: “A change made to how Cloudflare’s Web

Read More »

BGN Plans Global Gas Push Ahead of New Supplies

Energy trader BGN is set to expand its fledgling natural gas business into a global portfolio with stakes in plants, vessels and pipelines.  The push comes as the market for liquefied natural gas is set to boom, with US exports ramping up and Qatar, another major producer, also adding output. While that’s likely to push prices lower, the wave of extra supplies is poised to create new trading opportunities. The firm is in talks to buy LNG on contracts as long as 15 years, as well as equity in U.S. export plants, the company’s co-heads of LNG, Ruben Mosquera Arias and Maria Eugenia Suardiaz, said in an interview in Istanbul on Thursday. BGN got its start in the market for liquefied petroleum gas and has amassed a fleet of about 40 ships. In recent years, it has expanded rapidly into crude, oil products and metals.    “In LNG, we would like to be present globally as well, from the Atlantic basin to Asia Pacific,” said Suardiaz, declining to provide details on the volume they plan to handle.  Producers are set to add a record 300 billion cubic meters of annual export capacity by 2030, the International Energy Agency wrote last month in a report. That’s poised to reshape the market after years of scarcity. “We want to capture this wave,” said Mosquera Arias.  The company is also applying for licenses to buy capacity in European pipelines. It expects to take delivery of its first newbuild LNG carriers in the next two years, although the executives declined to provide more details.  BGN started its LNG team in 2024 and sold spot cargoes to both Egypt and Germany earlier this year. In the summer, it struck a deal to supply as many as 42 shipments to the North African country, where it’s already a major

Read More »

Crude Finishes Higher on Short Covering

Oil gained, finishing the week positive as investors assessed the murky outlook for a cease-fire in Ukraine and as the commodity pushed past an important technical level. West Texas Intermediate rose 0.7% to settle above $60 a barrel, signaling that a risk premium persists as a peace deal between Russia and Ukraine remains elusive. Ukrainian negotiators continued talks with US officials in Florida for a second day, with Russia objecting to some of the points in a US-backed plan. The market is watching for progress on a settlement that could lower prices by potentially easing sanctions and boosting Russian oil flows just as an expected oversupply in the market starts to materialize. But an agreement appears distant: Ukraine took credit for an overnight attack on Russia’s Syzran refinery and the Temryuk seaport. Meanwhile, Washington reportedly lobbied European countries in an effort to block a plan to use Moscow’s frozen assets to back a massive loan for Ukraine. Adding to bullish momentum, WTI on Friday settled above its 50-day moving average, a key level of support for the commodity. Prices have also received a boost from algorithmic traders covering some of their bearish positions in recent sessions — and analysts say more buying could materialize in coming weeks. “This session should mark the first notable short covering program since algo selling activity exhausted itself, and the bar is low for subsequent CTA buying activity to hit the tapes over the coming week,” said Dan Ghali, a commodity strategist at TD Securities. Countering geopolitical risks, oversupply is putting downward pressure on prices globally. Saudi Aramco will reduce the price of its flagship Arab Light crude grade to the lowest level since 2021 for January, while Canadian oil has tumbled. And the number of crude oil rigs in the US rose by 6

Read More »

ITT Agrees to Buy Lone Star’s SPX Flow in $4.8B Deal

ITT Inc. has agreed to acquire industrial equipment manufacturer SPX Flow Inc. from Lone Star Funds in a $4.775 billion cash and stock deal. The deal will will consist of a combination of cash and $700 million in ITT common stock issued to Lone Star, according to a statement confirming an earlier report by Bloomberg News that the companies were nearing a deal. Charlotte, North Carolina-based SPX Flow makes products including valves and pumps under brands such as APV and Johnson Pump, as well as food processing equipment such as its Gerstenberg Schröder-branded butter maker. Lone Star Funds agreed in 2021 to take SPX Flow private for $3.8 billion including debt.  The SPX Flow acquisition is the largest ever by Stamford, Connecticut-based ITT, according to data compiled by Bloomberg. ITT’s shares have gained 28% this year, giving it a market value of $14.3 billion. ITT’s history dates to 1920, with its genesis as International Telephone and Telegraph, a provider of telephone switching equipment and services, according to the company’s website. In 1995, that conglomerate was split into three divisions, including the company that became the current manufacturer of components and technology for a range of transportation, industrial and energy markets. WHAT DO YOU THINK? Generated by readers, the comments included herein do not reflect the views and opinions of Rigzone. All comments are subject to editorial review. Off-topic, inappropriate or insulting comments will be removed.

Read More »

Energy Department Launches Breakthrough AI-Driven Biotechnology Platform at PNNL

Richland, Wash.—U.S. Secretary of Energy Chris Wright launched a new chapter to secure American leadership in autonomous biological discovery yesterday alongside scientists and private partners at Pacific Northwest National Laboratory (PNNL). As part of his visit to PNNL, Secretary Wright commissioned and signed the Anaerobic Microbial Phenotyping Platform (AMP2). PNNL scientists believe AMP2 will be the world’s largest autonomous-capable science system for anaerobic microbial experimentation. The platform supports the Trump Administration’s recently announced Genesis Mission, which calls on the Department of Energy (DOE) to transform American leadership in science and innovation with the development of artificial intelligence (AI). Built by Gingko Bioworks, AMP2 gives DOE scientists an unprecedented capability to explore the world of microbes—an invisible yet powerful workforce poised to boost biotech manufacturing as well as provide insights into basic life science questions. This first-of-its-kind capability will transform how the U.S. identifies, grows, and optimizes the use of microbes in days and weeks instead of years using automation and AI.  “President Trump launched the Genesis Mission to ensure American leadership in science and innovation,” said Secretary Chris Wright. “This ongoing public-private partnership at PNNL will help do exactly that in the field of biotechnology. By launching AI-enabled, autonomous platforms like AMP2, our DOE National Laboratories are driving scientific breakthroughs faster than ever before and ensuring the United States leads the world in technologies that will better human lives and secure our future.”  The AMP2 platform will serve as a prototype for DOE’s planned development of the larger Microbial Molecular Phenotyping Capability (M2PC). Together, the systems will establish the world’s largest autonomous microbial research infrastructure, and position the U.S. to lead in biotechnology, biomanufacturing, and next-generation materials innovation for decades to come. Secretary Wright visited PNNL as part of his ongoing tour of all 17 DOE National Laboratories. PNNL marks

Read More »

Chevron, Gorgon Partners OK $2B to Drill for More Gas

Chevron Corp’s Australian unit and its joint venture partners have reached a final investment decision to further develop the massive Gorgon natural gas project in Western Australia, it said in a statement on Friday. Chevron Australia and its partners — including Exxon Mobil Corp. and Shell Plc — will spend A$3 billion ($2 billion) connecting two offshore natural gas fields to existing infrastructure and processing facilities on Barrow Island as part of the Gorgon Stage 3 development, it said in the statement. Six wells will also be drilled.  Gorgon, on the remote Barrow Island in northwestern Australia, is the largest resource development in Australia’s history, and produces about 15.6 million tons of liquefied natural gas a year. WHAT DO YOU THINK? Generated by readers, the comments included herein do not reflect the views and opinions of Rigzone. All comments are subject to editorial review. Off-topic, inappropriate or insulting comments will be removed.

Read More »

USA Crude Oil Stocks Rise Week on Week

U.S. commercial crude oil inventories, excluding those in the Strategic Petroleum Reserve (SPR), increased by 0.6 million barrels from the week ending November 21 to the week ending November 28, the U.S. Energy Information Administration (EIA) highlighted in its latest weekly petroleum status report. That EIA report was released on December 3 and included data for the week ending November 28. It showed that crude oil stocks, not including the SPR, stood at 427.5 million barrels on November 28, 426.9 million barrels on November 21, and 423.4 million barrels on November 29, 2024. Crude oil in the SPR stood at 411.7 million barrels on November 28, 411.4 million barrels on November 21, and 391.8 million barrels on November 29, 2024, the report revealed. Total petroleum stocks – including crude oil, total motor gasoline, fuel ethanol, kerosene type jet fuel, distillate fuel oil, residual fuel oil, propane/propylene, and other oils – stood at 1.687 billion barrels on November 28, the report showed. Total petroleum stocks were up 5.5 million barrels week on week and up 58.5 million barrels year on year, the report pointed out. “At 427.5 million barrels, U.S. crude oil inventories are about three percent below the five year average for this time of year,” the EIA noted in its latest weekly petroleum status report. “Total motor gasoline inventories increased by 4.5 million barrels from last week and are about two percent below the five year average for this time of year. Finished gasoline and blending components inventories increased last week,” it added. “Distillate fuel inventories increased by 2.1 million barrels last week and are about seven percent below the five year average for this time of year. Propane/propylene inventories decreased 0.7 million barrels from last week and are about 15 percent above the five year average for this

Read More »

At the Crossroads of AI and the Edge: Inside 1623 Farnam’s Rising Role as a Midwest Interconnection Powerhouse

That was the thread that carried through our recent conversation for the DCF Show podcast, where Severn walked through the role Farnam now plays in AI-driven networking, multi-cloud connectivity, and the resurgence of regional interconnection as a core part of U.S. digital infrastructure. Aggregation, Not Proximity: The Practical Edge Severn is clear-eyed about what makes the edge work and what doesn’t. The idea that real content delivery could aggregate at the base of cell towers, he noted, has never been realistic. The traffic simply isn’t there. Content goes where the network already concentrates, and the network concentrates where carriers, broadband providers, cloud onramps, and CDNs have amassed critical mass. In Farnam’s case, that density has grown steadily since the building changed hands in 2018. At the time an “underappreciated asset,” the facility has since become a meeting point for more than 40 broadband providers and over 60 carriers, with major content operators and hyperscale platforms routing traffic directly through its MMRs. That aggregation effect feeds on itself; as more carrier and content traffic converges, more participants anchor themselves to the hub, increasing its gravitational pull. Geography only reinforces that position. Located on the 41st parallel, the building sits at the historical shortest-distance path for early transcontinental fiber routes. It also lies at the crossroads of major east–west and north–south paths that have made Omaha a natural meeting point for backhaul routes and hyperscale expansions across the Midwest. AI and the New Interconnection Economy Perhaps the clearest sign of Farnam’s changing role is the sheer volume of fiber entering the building. More than 5,000 new strands are being brought into the property, with another 5,000 strands being added internally within the Meet-Me Rooms in 2025 alone. These are not incremental upgrades—they are hyperscale-grade expansions driven by the demands of AI traffic,

Read More »

Schneider Electric’s $2.3 Billion in AI Power and Cooling Deals Sends Message to Data Center Sector

When Schneider Electric emerged from its 2025 North American Innovation Summit in Las Vegas last week with nearly $2.3 billion in fresh U.S. data center commitments, it didn’t just notch a big sales win. It arguably put a stake in the ground about who controls the AI power-and-cooling stack over the rest of this decade. Within a single news cycle, Schneider announced: Together, the deals total about $2.27 billion in U.S. data center infrastructure, a number Schneider confirmed in background with multiple outlets and which Reuters highlighted as a bellwether for AI-driven demand.  For the AI data center ecosystem, these contracts function like early-stage fuel supply deals for the power and cooling systems that underpin the “AI factory.” Supply Capacity Agreements: Locking in the AI Supply Chain Significantly, both deals are structured as supply capacity agreements, not traditional one-off equipment purchase orders. Under the SCA model, Schneider is committing dedicated manufacturing lines and inventory to these customers, guaranteeing output of power and cooling systems over a multi-year horizon. In return, Switch and Digital Realty are providing Schneider with forecastable volume and visibility at the scale of gigawatt-class campus build-outs.  A Schneider spokesperson told Reuters that the two contracts are phased across 2025 and 2026, underscoring that this arrangement is about pipeline, as opposed to a one-time backlog spike.  That structure does three important things for the market: Signals confidence that AI demand is durable.You don’t ring-fence billions of dollars of factory output for two customers unless you’re highly confident the AI load curve runs beyond the current GPU cycle. Pre-allocates power & cooling the way the industry pre-allocated GPUs.Hyperscalers and neoclouds have already spent two years locking up Nvidia and AMD capacity. These SCAs suggest power trains and thermal systems are joining chips on the list of constrained strategic resources.

Read More »

The Data Center Power Squeeze: Mapping the Real Limits of AI-Scale Growth

As we all know, the data center industry is at a crossroads. As artificial intelligence reshapes the already insatiable digital landscape, the demand for computing power is surging at a pace that outstrips the growth of the US electric grid. As engines of the AI economy, an estimated 1,000 new data centers1 are needed to process, store, and analyze the vast datasets that run everything from generative models to autonomous systems. But this transformation comes with a steep price and the new defining criteria for real estate: power. Our appetite for electricity is now the single greatest constraint on our expansion, threatening to stall the very innovation we enable. In 2024, US data centers consumed roughly 4% of the nation’s total electricity, a figure that is projected to triple by 2030, reaching 12% or more.2 For AI-driven hyperscale facilities, the numbers are even more staggering. With the largest planned data centers requiring gigawatts of power, enough to supply entire cities, the cumulative demand from all data centers is expected to reach 134 gigawatts by 2030, nearly three times the current load.​3 This presents a systemic challenge. The U.S. power grid, built for a different era, is struggling to keep pace. Utilities are reporting record interconnection requests, with some regions seeing demand projections that exceed their total system capacity by fivefold.4 In Virginia and Texas, the epicenters of data center expansion, grid operators are warning of tight supply-demand balances and the risk of blackouts during peak periods.5 The problem is not just the sheer volume of power needed, but the speed at which it must be delivered. Data center operators are racing to secure power for projects that could be online in as little as 18 months, but grid upgrades and new generation can take years, if not decades. The result

Read More »

The Future of Hyperscale: Neoverse Joins NVLink Fusion as SC25 Accelerates Rack-Scale AI Architectures

Neoverse’s Expanding Footprint and the Power-Efficiency Imperative With Neoverse deployments now approaching roughly 50% of all compute shipped into top hyperscalers in 2025 (representing more than a billion Arm cores) and with nation-scale AI campuses such as the Stargate project already anchored on Arm compute, the addition of NVLink Fusion becomes a pivotal extension of the Neoverse roadmap. Partners can now connect custom Arm CPUs to their preferred NVIDIA accelerators across a coherent, high-bandwidth, rack-scale fabric. Arm characterized the shift as a generational inflection point in data-center architecture, noting that “power—not FLOPs—is the bottleneck,” and that future design priorities hinge on maximizing “intelligence per watt.” Ian Buck, vice president and general manager of accelerated computing at NVIDIA, underscored the practical impact: “Folks building their own Arm CPU, or using an Arm IP, can actually have access to NVLink Fusion—be able to connect that Arm CPU to an NVIDIA GPU or to the rest of the NVLink ecosystem—and that’s happening at the racks and scale-up infrastructure.” Despite the expanded design flexibility, this is not being positioned as an open interconnect ecosystem. NVIDIA continues to control the NVLink Fusion fabric, and all connections ultimately run through NVIDIA’s architecture. For data-center planners, the SC25 announcement translates into several concrete implications: 1.   NVIDIA “Grace-style” Racks Without Buying Grace With NVLink Fusion now baked into Neoverse, hyperscalers and sovereign operators can design their own Arm-based control-plane or pre-processing CPUs that attach coherently to NVIDIA GPU domains—such as NVL72 racks or HGX B200/B300 systems—without relying on Grace CPUs. A rack-level architecture might now resemble: Custom Neoverse SoC for ingest, orchestration, agent logic, and pre/post-processing NVLink Fusion fabric Blackwell GPU islands and/or NVLink-attached custom accelerators (Marvell, MediaTek, others) This decouples CPU choice from NVIDIA’s GPU roadmap while retaining the full NVLink fabric. In practice, it also opens

Read More »

Flex’s Integrated Data Center Bet: How a Manufacturing Giant Plans to Reshape AI-Scale Infrastructure

At this year’s OCP Global Summit, Flex made a declaration that resonated across the industry: the era of slow, bespoke data center construction is over. AI isn’t just stressing the grid or forcing new cooling techniques—it’s overwhelming the entire design-build process. To meet this moment, Flex introduced a globally manufactured, fully integrated data center platform aimed directly at multi-gigawatt AI campuses. The company claims it can cut deployment timelines by as much as 30 percent by shifting integration upstream into the factory and unifying power, cooling, compute, and lifecycle services into pre-engineered modules. This is not a repositioning on the margins. Flex is effectively asserting that the future hyperscale data center will be manufactured like a complex industrial system, not built like a construction project. On the latest episode of The Data Center Frontier Show, we spoke with Rob Campbell, President of Flex Communications, Enterprise & Cloud, and Chris Butler, President of Flex Power, about why Flex believes this new approach is not only viable but necessary in the age of AI. The discussion revealed a company leaning heavily on its global manufacturing footprint, its cross-industry experience, and its expanding cooling and power technology stack to redefine what deployment speed and integration can look like at scale. AI Has Broken the Old Data Center Model From the outset, Campbell and Butler made clear that Flex’s strategy is a response to a structural shift. AI workloads no longer allow power, cooling, and compute to evolve independently. Densities have jumped so quickly—and thermals have risen so sharply—that the white space, gray space, and power yard are now interdependent engineering challenges. Higher chip TDPs, liquid-cooled racks approaching one to two megawatts, and the need to assemble entire campuses in record time have revealed deep fragility in traditional workflows. As Butler put it, AI

Read More »

Data Center Jobs: Engineering, Construction, Commissioning, Sales, Field Service and Facility Tech Jobs Available in Major Data Center Hotspots

Each month Data Center Frontier, in partnership with Pkaza, posts some of the hottest data center career opportunities in the market. Here’s a look at some of the latest data center jobs posted on the Data Center Frontier jobs board, powered by Pkaza Critical Facilities Recruiting. Looking for Data Center Candidates? Check out Pkaza’s Active Candidate / Featured Candidate Hotlist Data Center Facility Technician (All Shifts Available) Impact, TX This position is also available in: Ashburn, VA; Abilene, TX; Needham, MA and New York, NY. Navy Nuke / Military Vets leaving service accepted!  This opportunity is working with a leading mission-critical data center provider. This firm provides data center solutions custom-fit to the requirements of their client’s mission-critical operational facilities. They provide reliability of mission-critical facilities for many of the world’s largest organizations facilities supporting enterprise clients, colo providers and hyperscale companies. This opportunity provides a career-growth minded role with exciting projects with leading-edge technology and innovation as well as competitive salaries and benefits. Electrical Commissioning Engineer Montvale, NJ This traveling position is also available in: New York, NY; White Plains, NY;  Richmond, VA; Ashburn, VA; Charlotte, NC; Atlanta, GA; Hampton, GA; Fayetteville, GA; New Albany, OH; Cedar Rapids, IA; Phoenix, AZ; Salt Lake City, UT; Dallas, TX or Chicago, IL. *** ALSO looking for a LEAD EE and ME CxA Agents and CxA PMs. *** Our client is an engineering design and commissioning company that has a national footprint and specializes in MEP critical facilities design. They provide design, commissioning, consulting and management expertise in the critical facilities space. They have a mindset to provide reliability, energy efficiency, sustainable design and LEED expertise when providing these consulting services for enterprise, colocation and hyperscale companies. This career-growth minded opportunity offers exciting projects with leading-edge technology and innovation as well as competitive salaries and

Read More »

Microsoft will invest $80B in AI data centers in fiscal 2025

And Microsoft isn’t the only one that is ramping up its investments into AI-enabled data centers. Rival cloud service providers are all investing in either upgrading or opening new data centers to capture a larger chunk of business from developers and users of large language models (LLMs).  In a report published in October 2024, Bloomberg Intelligence estimated that demand for generative AI would push Microsoft, AWS, Google, Oracle, Meta, and Apple would between them devote $200 billion to capex in 2025, up from $110 billion in 2023. Microsoft is one of the biggest spenders, followed closely by Google and AWS, Bloomberg Intelligence said. Its estimate of Microsoft’s capital spending on AI, at $62.4 billion for calendar 2025, is lower than Smith’s claim that the company will invest $80 billion in the fiscal year to June 30, 2025. Both figures, though, are way higher than Microsoft’s 2020 capital expenditure of “just” $17.6 billion. The majority of the increased spending is tied to cloud services and the expansion of AI infrastructure needed to provide compute capacity for OpenAI workloads. Separately, last October Amazon CEO Andy Jassy said his company planned total capex spend of $75 billion in 2024 and even more in 2025, with much of it going to AWS, its cloud computing division.

Read More »

John Deere unveils more autonomous farm machines to address skill labor shortage

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Self-driving tractors might be the path to self-driving cars. John Deere has revealed a new line of autonomous machines and tech across agriculture, construction and commercial landscaping. The Moline, Illinois-based John Deere has been in business for 187 years, yet it’s been a regular as a non-tech company showing off technology at the big tech trade show in Las Vegas and is back at CES 2025 with more autonomous tractors and other vehicles. This is not something we usually cover, but John Deere has a lot of data that is interesting in the big picture of tech. The message from the company is that there aren’t enough skilled farm laborers to do the work that its customers need. It’s been a challenge for most of the last two decades, said Jahmy Hindman, CTO at John Deere, in a briefing. Much of the tech will come this fall and after that. He noted that the average farmer in the U.S. is over 58 and works 12 to 18 hours a day to grow food for us. And he said the American Farm Bureau Federation estimates there are roughly 2.4 million farm jobs that need to be filled annually; and the agricultural work force continues to shrink. (This is my hint to the anti-immigration crowd). John Deere’s autonomous 9RX Tractor. Farmers can oversee it using an app. While each of these industries experiences their own set of challenges, a commonality across all is skilled labor availability. In construction, about 80% percent of contractors struggle to find skilled labor. And in commercial landscaping, 86% of landscaping business owners can’t find labor to fill open positions, he said. “They have to figure out how to do

Read More »

2025 playbook for enterprise AI success, from agents to evals

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More 2025 is poised to be a pivotal year for enterprise AI. The past year has seen rapid innovation, and this year will see the same. This has made it more critical than ever to revisit your AI strategy to stay competitive and create value for your customers. From scaling AI agents to optimizing costs, here are the five critical areas enterprises should prioritize for their AI strategy this year. 1. Agents: the next generation of automation AI agents are no longer theoretical. In 2025, they’re indispensable tools for enterprises looking to streamline operations and enhance customer interactions. Unlike traditional software, agents powered by large language models (LLMs) can make nuanced decisions, navigate complex multi-step tasks, and integrate seamlessly with tools and APIs. At the start of 2024, agents were not ready for prime time, making frustrating mistakes like hallucinating URLs. They started getting better as frontier large language models themselves improved. “Let me put it this way,” said Sam Witteveen, cofounder of Red Dragon, a company that develops agents for companies, and that recently reviewed the 48 agents it built last year. “Interestingly, the ones that we built at the start of the year, a lot of those worked way better at the end of the year just because the models got better.” Witteveen shared this in the video podcast we filmed to discuss these five big trends in detail. Models are getting better and hallucinating less, and they’re also being trained to do agentic tasks. Another feature that the model providers are researching is a way to use the LLM as a judge, and as models get cheaper (something we’ll cover below), companies can use three or more models to

Read More »

OpenAI’s red teaming innovations define new essentials for security leaders in the AI era

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More OpenAI has taken a more aggressive approach to red teaming than its AI competitors, demonstrating its security teams’ advanced capabilities in two areas: multi-step reinforcement and external red teaming. OpenAI recently released two papers that set a new competitive standard for improving the quality, reliability and safety of AI models in these two techniques and more. The first paper, “OpenAI’s Approach to External Red Teaming for AI Models and Systems,” reports that specialized teams outside the company have proven effective in uncovering vulnerabilities that might otherwise have made it into a released model because in-house testing techniques may have missed them. In the second paper, “Diverse and Effective Red Teaming with Auto-Generated Rewards and Multi-Step Reinforcement Learning,” OpenAI introduces an automated framework that relies on iterative reinforcement learning to generate a broad spectrum of novel, wide-ranging attacks. Going all-in on red teaming pays practical, competitive dividends It’s encouraging to see competitive intensity in red teaming growing among AI companies. When Anthropic released its AI red team guidelines in June of last year, it joined AI providers including Google, Microsoft, Nvidia, OpenAI, and even the U.S.’s National Institute of Standards and Technology (NIST), which all had released red teaming frameworks. Investing heavily in red teaming yields tangible benefits for security leaders in any organization. OpenAI’s paper on external red teaming provides a detailed analysis of how the company strives to create specialized external teams that include cybersecurity and subject matter experts. The goal is to see if knowledgeable external teams can defeat models’ security perimeters and find gaps in their security, biases and controls that prompt-based testing couldn’t find. What makes OpenAI’s recent papers noteworthy is how well they define using human-in-the-middle

Read More »